January 13, 2020
Type 2 diabetes management company Virta announced a whopping $93 million Series C financing round late last week. The latest round was led by Caffeinated Capital with participation from Venrock, Obvious Ventures, Creandum, Playground Global and SciFi VC.
This announcement brings the company’s total funding pot to around $166 million, coming roughly a year-and-a-half after its Series B round,...
April 17, 2019
Healthcare professionals believing that the Apple Watch is going to be a clinically useful tool edged out those seeing it as a consumer fad — but just barely in the new 2019 Venrock Healthcare Prognosis report. The report, conducted by the venture capital firm Venrock, surveyed 250 industry players, including health IT startups, large employers, insurance companies, healthcare providers,...
May 1, 2018
Suki, a startup that makes an AI-powered and voice-enabled digital assistant for doctors, has just landed $20 million in a funding round led by Venrock, with participation from First Round, Social Capital, and Marc Benioff.
The technology was developed to help doctors handle paperwork and update a patient's EHR. The technology is also designed to gradually personalize itself based on each...
April 27, 2018
According to a group of 300 healthcare stakeholders surveyed in Venrock's 2018 Healthcare Prognosis Survey, Amazon is the tech company to watch in the healthcare space — even if they're pretty well split on the prospects for the Amazon-JP Morgan-Berkshire Hathaway project.
When asked which of five tech companies (Amazon, Apple, Google, Microsoft, and IBM) would make the most progress in 2018, 51...
April 13, 2017
It’s hard to characterize what the future of healthcare IT will look like without evoking some form of the word “uncertainty.” With regulatory changes ahead and a fuzzy idea of the economy will look, barriers to innovation are expected. Yet a new survey from VC group Venrock shows many professionals in the industry still expect healthcare IT to grow over the next few years, and even think some...
March 8, 2017
San Francisco-based startup Virta Health officially launched today with a mission to reverse type 2 diabetes. Formed by a team of doctors, scientists and technologists hailing from Stanford, MIT and Harvard – and backed by $37 million from some big name investors – Virta is approaching type 2 diabetes with a goal to use personalized nutrition, one-on-one coaching and remote monitoring to reverse...
January 10, 2017
Bethesda, Maryland-based Aledade, which partners with primary care physicians to create tech-enabled accountable care organizations, has raised $20 million in a round led by Biomatics Capital, GV and Maryland Venture Fund. Existing investors Venrock and ARCH Venture Partners also contributed to the round. This brings the company’s total funding to $54.5 million.
The funding, which was announced...
January 5, 2017
Diabetes management device maker Intuity Medical has raised another $15 million in Series C funding in a round led by PTV Healthcare Capital, new investors KCK Group, and affiliates of Luther King Capital Management. Existing investors Accuitive Medical Ventures, Investor Growth Capital, US Venture Partners, Venrock and Versant Ventures also contributed to the round.
The company, which makes an...
October 14, 2015
Lyra Health, the behavioral health-focused startup launched this summer by David Ebersman, former CFO of Facebook and Genentech, has raised $35 million. Greylock Partners and existing investor Venrock led the round, with additional participation from existing investor Castlight Health, and new investors Providence Health & Services, Breyer Capital, and Origin Capital...
August 20, 2015
Bryan Roberts, one of Venrock's healthcare-focused investment partners, has some rules of thumb for investing in digital health -- and for what to pass up. Roberts' portfolio included six successful exits last year, the Wall Street Journal reports, and this year he has invested in Stride Health, Lyra Health, Intarcia Therapeutics, and Grand Rounds.
In a recent interview with the...